Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Pisansky

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA eraDeborah A Kuban, Howard D Thames, Larry B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2008
Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancerColleen A F Lawton, Jeff Michalski, Issam El-Naqa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancerEdith A Perez, Vera J Suman, Nancy E Davidson, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2018
A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526)Juanita M Crook, Peixin Zhang, Thomas M Pisansky, et al.
The Prostate|July 5, 2022
A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of lifeWilliam W Wong, David W Hillman, Thomas B Daniels, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2016
Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple MetastasesHania A Al-Hallaq, Steven J Chmura, Joseph K Salama, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groupsHoward D Thames, Deborah A Kuban, Michelle L DeSilvio, et al.
Bladder (San Francisco, Calif.)|August 11, 2020
Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysisTyler J Wilhite, David Routman, Andrea L Arnett, et al.
The Journal of Urology|February 16, 2005
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysisEric M Horwitz, Howard D Thames, Deborah A Kuban, et al.
Journal of Radiation Oncology|September 28, 2013
Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate CancerMichael G Heckman, Katherine S Tzou, Alexander S Parker, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
International Journal of Radiation Oncology, Biology, Physics|October 25, 2003
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA eraDeborah A Kuban, Howard D Thames, Larry B Levy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2008
Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancerColleen A F Lawton, Jeff Michalski, Issam El-Naqa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancerEdith A Perez, Vera J Suman, Nancy E Davidson, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2018
A Prospective Phase 2 Trial of Transperineal Ultrasound-Guided Brachytherapy for Locally Recurrent Prostate Cancer After External Beam Radiation Therapy (NRG Oncology/RTOG-0526)Juanita M Crook, Peixin Zhang, Thomas M Pisansky, et al.
The Prostate|July 5, 2022
A Phase II prospective study of hypofractionated proton therapy of prostate and pelvic lymph nodes: Acute effects on patient-reported quality of lifeWilliam W Wong, David W Hillman, Thomas B Daniels, et al.
International Journal of Radiation Oncology, Biology, Physics|November 16, 2016
Benchmark Credentialing Results for NRG-BR001: The First National Cancer Institute-Sponsored Trial of Stereotactic Body Radiation Therapy for Multiple MetastasesHania A Al-Hallaq, Steven J Chmura, Joseph K Salama, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2006
Increasing external beam dose for T1-T2 prostate cancer: effect on risk groupsHoward D Thames, Deborah A Kuban, Michelle L DeSilvio, et al.
Bladder (San Francisco, Calif.)|August 11, 2020
Increased utilization of external beam radiotherapy relative to cystectomy for localized, muscle-invasive bladder cancer: a SEER analysisTyler J Wilhite, David Routman, Andrea L Arnett, et al.
The Journal of Urology|February 16, 2005
Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysisEric M Horwitz, Howard D Thames, Deborah A Kuban, et al.
Journal of Radiation Oncology|September 28, 2013
Lack of Association between COX-2 Staining Level and Biochemical Recurrence Following Salvage Radiation Therapy for Recurrent Prostate CancerMichael G Heckman, Katherine S Tzou, Alexander S Parker, et al.
Pageof 14